ALZCUR.ST Gross Margin

The Gross Margin of AlzeCure Pharma AB (ALZCUR.ST) is 7775.20%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

ALZCUR.ST Gross Margin - Historical Value

Date	Value
2024-12-31	7775.20%

ALZCUR.ST Gross Margin - Peers Comparison

Ticker	Name	Value
IMM.L	ImmuPharma PLC	100.00%
ORX.ST	Orexo AB	87.78%
SECARE.ST	Swedencare AB (publ)	36.83%
SKIN.SW	Cassiopea SpA	100.00%
AB.PA	AB Science SA	60.52%
ALTHX.PA	Theranexus SA	-217.60%
CLBIO.ST	Corline Biomedical AB	137.50%
INDEX.ST	InDex Pharmaceuticals Holding AB	-81.95%
KDEV.ST	Karolinska Development AB	-350.07%
KLAR.ST	Klaria Pharma Holding AB (publ)	100.00%
RECI B.ST	Recipharm AB (publ)	48.38%
SAR.L	Sareum Holdings PLC	-41.33%
GABA.ST	Gabather AB	7775.20%
HRTIS.HE	Herantis Pharma Oyj	-7.12%
STX.L	Shield Therapeutics PLC	30.78%
ENZY.ST	Enzymatica AB (publ)	67.40%
IBT B.ST	Infant Bacterial Therapeutics AB	7775.20%
KARO.ST	Karo Pharma AB	57.62%
MOB.ST	Moberg Pharma AB (publ)	64.37%
TMBR	Timber Pharmaceuticals Inc	-50.00%
ARTL	Artelo Biosciences Inc	7775.20%
AVCN.TO	Avicanna Inc	45.38%
BETR.CN	BetterLife Pharma Inc	7775.20%
NFX.L	Nuformix PLC	96.60%
NWRN.SW	Newron Pharmaceuticals SpA	98.26%
ASAP.ST	Asarina Pharma AB (publ)	7775.20%
CALTX.ST	Calliditas Therapeutics AB	94.99%
FUM.L	Futura Medical PLC	69.58%
LIPI.ST	Lipidor AB	-82.31%
REDX.L	Redx Pharma PLC	88.82%
ANNX.ST	Annexin Pharmaceuticals AB (publ)	7775.20%
IRLAB A.ST	IRLAB Therapeutics AB	-44.03%
CAMX.ST	Camurus AB	93.07%
TCCR	Triccar Inc	37.67%